October 3, 2022
mayank
Nippon India Pharma Fund
NAV Growth: Rs 306.5494
NAV IDCW: Rs 104.6828
NAV Bonus: Rs 306.5494
Suitable For Which Investors?
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route.
Fund’s Investment Strategy:
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Fund Manager:
1) Sailesh Raj Bhan
Education: Mr. Bhan is an MBA (Finance) and CFA.
Experience: Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst – Equity Research.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 1,000 |
| Min. Withdrawal (Rs) | 100 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | 1 |
| Lock-in Period | NA |
| Exit Load | 1% for redemption within 30 days |
Basic Details
| Fund House | Nippon India Mutual Fund |
| Launch Date | 01-Jan-13 |
| Return Since Launch | 16.38% |
| Benchmark | S&P BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets | Rs 4,588 Cr |
| (As on 31-Aug-2022) | |
| Expense Ratio | 1.00% |
| (As on 31-Aug-2022) | |
| Risk Grade | — |
| Return Grade | — |
| Turnover | 27.00% |
Nippon India Pharma Fund Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| Nippon Ind Pharma Dir | -9.41 | 0.81 | 2.22 | 8.46 | -2.29 | -7.4 | 27.35 | 18.01 | 10.04 | — |
| S&P BSE Healthcare TRI | -10.34 | 0.67 | 1.45 | 8.47 | -3.49 | -9.92 | 23.95 | 12.32 | 4.63 | — |
| Equity: Sectoral-Pharma | -8.75 | 0.69 | 1.85 | 7.97 | -2.64 | -8.05 | 26.66 | 15.68 | 7.9 | — |
| Rank within category | 8 | 4 | 4 | 6 | 4 | 5 | 5 | 1 | 1 | — |
| Number of funds in category | 11 | 11 | 11 | 11 | 11 | 10 | 9 | 4 | 3 | 0 |
Nippon India Pharma Fund Peer Comparison
| Fund name | Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) |
| Nippon Ind Pharma Dir | Unrated | -7.40 | 27.35 | 18.01 | 1.00 | 4,588 | 16.38 | 1.00 (30) | 9yrs 9mo | 27.00 |
| ICICI Pru Pharma Hlthcr & Diagn Dir | Unrated | -9.07 | 28.03 | — | 1.22 | 2,465 | 18.05 | 1.00 (15) | 4yrs 2mo | 45.00 |
| Mirae Asset Helthcr Dir | Unrated | -6.23 | 31.51 | — | 0.56 | 1,723 | 22.17 | 1.00 (365) | 4yrs 3mo | 26.00 |
| SBI Helthcr Opp Dir | Unrated | -5.75 | 27.52 | 13.63 | 1.06 | 1,675 | 15.34 | 0.50 (15) | 9yrs 9mo | 27.00 |
| DSP Helthcr Dir | Unrated | -8.52 | 30.54 | — | 0.82 | 1,161 | 23.34 | 1.00 (364) | 3yrs 10mo | 10.00 |
Portfolio Analysis
| No. of Stocks | 28 |
| Top 10 Stocks | 68.97% |
| Top 5 Stocks | 44.11% |
| Top 3 Sectors | 99.68% |
| Portfolio P/B Ratio | 4.17 |
| Portfolio P/E Ratio | 30.50 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 40,521 | 55,278 |
| Giant (%) | 14.26 | 19.26 |
| Large (%) | 32.20 | 36.52 |
| Mid (%) | 45.45 | 36.17 |
| Small (%) | 8.10 | 7.94 |
| Tiny (%) | — | 0.55 |
Chanakya’s Mutual Fund Guidance For Nippon India Pharma Fund
Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Apply Online: https://www.ni-mf.in/LsK2SG
Stock Research Reports:
https://www.analysislibrary.com/
NFO Guidance:
https://sahifund.com/category/nfos/
Chanakya’s Mutual Fund Guidance on YouTube
https://www.youtube.com/c/ChanakyaNiPothi
Join Chanakya’s Telegram Channel @
https://t.me/chanakyanipothi